Hematopoietic growth factors not only modulate blood progenitor cell activity but also alter the function of mature phagocytes. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF; 1 ng/mL for 60 min) did not stimulate luminol-enhanced chemiluminescence of polymorphonuclear leukocytes (PMNs) in suspension but primed PMN for as much as a 15-fold increase in chemiluminescence in response to f-met-leu-phe (fMLP). Mixed mononuclear leukocytes (monocytes [-20%] and lymphocytes [-80%]; MNL) chemiluminescence was very low even after rhGM-CSF priming, but MNLsadded to the PMNs (PMN-MNL) resulted in near doubling of rhGM-CSF-primed PMN fMLP-stimulated chemiluminescence. The enhancing factor(s) from MNLs were inherent rather than induced by the GM-CSF, and purified lymphocytes increased GM-CSFprimed PMN chemiluminescence equal to mixed MNLs. We could not detect cell-free "enhancing factor(s)," but cellto-cell contact further enhanced rhGM-CSF-primed fMLPstimulated PMN-MNL oxidative activity by 40%. Polyclonal EMATOPOIETIC GROWTH factors are low molec-
H ular weight glycoprotein cytokines that regulate the maintenance, replication, and differentiation of blood progenitor cells. Human-derived granulocyte-macrophage a lony-stimulating (GM-CSF), granulocyte colony-stimulating factor (G-CSF), and interleukin-3 (IL-3) are three major growth factors that have been sequenced and cloned. There is a growing list of proposed applications for these growth factors, including treatment of cytopenias and infectious diseases, amelioration of myelosuppression induced by chemotherapy and radiotherapy and facilitation of bone marrow engraftment following transplantation.'-'' In addition to their proliferating and differentiating effects on blood progenitor cells, growth factors can also alter the activity of mature leukocytes.
The oxidative burst is triggered by ingestion of particles or microbes, by contact with certain biological surfaces, and by certain soluble molecules such as f-met-leu-phe (fh4LP) and endotoxin. Products of the oxidative burst serve important microbicidal and tumorcidal functions but can damage host tissue. Thus, knowledge of the influence of growth factors on the polymorphonuclear leukocyte (PMN) oxidative burst is important for evaluation of these factors for various clinical uses. The present study examines and compares the effects of human recombinant GM-CSF, G-CSF, and IL-3 on in vitro human PMN oxidative activity and explores the role of leukocyte interaction in growth factor stimulation of PMN oxidative activity.
MATERIALS AND METHODS

Materials
Luminol, fMLP, trypan blue, catalase, 0-dianisidine, human leukocyte myeloperoxidase (MPO), and ferricytochrome c were from Sigma Chemical Co (St Louis, MO). Ficoll-Hypaque was purchased from Flow Laboratories (McLean, VA) and Los Alamos Diagnostics (Los Alamos, NM). Hanks' balanced salt solution (HBSS) and the limulus amebocyte lysate assay kit were from Whittaker Bioproducts rabbit anti-tumor necrosis factor (TNF) (but not preimmune serum) decreased both fMLP-stimulated rhGM-CSFprimed PMNs and PMN-MNL chemiluminescence, suggesting that TNF on the PMN surface is enhancing GM-CSF-primed chemiluminescence. GM-CSF priming markedly increased PMN superoxide release (sevenfold), but PMN superoxide release was not further enhanced by the presence of MNLs. Recombinant human granulocyte colony-stimulating factor (rhG-CSF) and interleukin-3 (rhlL-3) displayed much smaller effects on pure PMNs and mixed PMN-MNL chemiluminescence and superoxide release than rhGM-CSF. rhGM-CSF primes PMNs for increased oxidative activity more than rhG-CSF and rhlL-3. Maximal oxidative activity was observed when mixed PMN-MNL were primed with GM-CSF in a cell pellet-promoting cell-to-cell contact. This enhanced activity can be attributed, in part, to both inherent enhancing factor(s) on lymphocytes and PMN-associated TNF induced by GM-CSF. Recombinant human granulocyte-macrophage colony-stimulating factor expressed in yeast (rhGM-CSFy; 5 X IO' colony forming units [CFUs]/mg), recombinant human granulocyte colony-stimulating factor expressed in yeast (rhG-CSF; 1 1.1 f 9.2 X lo7 CFUjmg), and recombinant human interleukin-3 expressed in yeast (IL-3; 0.9 to 6.7 X 10' CSU/mg) were supplied by Immunex Corp (Seattle, WA). rhGM-CSF expressed in Escherichia coli (1 to 5 X lo7 CFU/mL) was supplied by Behnngwerke AG, (Marburg, Germany). The endotoxin content of these growth factor preparations was i l ng/mg protein by limulus amebocyte lysate assay (Hoechst-Roussel Pharmaceuticals, Somerville, NJ).
Preimmune rabbit serum, rabbit polyclonal anti-human GM-CSF (10,000 neutralizing units (NU)/mL), rabbit polyclonal anti-human IL-1/3 (10,000 NU/mL), and rabbit polyclonal anti-human TNF (10,000 NU/mL) were purchased from Endogen Inc (Boston, MA).
Leukocyte Preparation
Purified PMNs (-98% PMNs and >95% viable by trypan blue exclusion) containing i l platelet/5 PMNs and 1 5 0 pg/mL endotoxin (limulus amebocyte lysate assay) were obtained from normal heparinized (10 U/mL) venous blood by a one-step ficoll-Hypaque sep- with or without rhGM-CSFe (1 ng/mL). The samples were then iced and the cells removed by centrifugation, yielding a cell-free PMN-MNL-conditioned medium.
Leukocyte Oxidative Activity
Chemiluminescence
Chemiluminescence is a measure of PMN oxidative activity. The light is emitted from unstable high-energy oxygen species generated by activated phagocytes.13 Purified PMNs (5 X lo5 PMNs) and/or MNLs (5 X IO5) were incubated in HBSS containing 0.1% human serum albumin ( I mL) with or without growth factors 0 to 120 minutes in a shaking water bath. Then luminol14 (1 X mol/L)-enhanced tMLP (1 pmol/L)-stimulated chemiluminescence was read with a Chronolog Photometer (Chrono-log Corp, Havertown, PA) at 37°C for 12 minutes. Chemiluminescence is reported as relative peak light emitted (= height of the curve) in arbitrary units (AU).
Superoxide Release
The growth factors were added to PMNs (5 X 105/mL), MNLs (5 X 105/mL), or PMNs (5 X 10S/mL) plus MNLs (5 X 105/mL), and the cells were pelleted by centrifugation ( I 50g X 5 min) into buttons.
The cell buttons were incubated for 60 minutes at 37°C and then resuspended by vortex agitation. Catalase (0.062 mg/mL) was added to prevent HzOz reoxidation of cytochrome e." Cytochrome c (120 pmol/L) and fMLP mol/L) were added to the cells and the samples incubated for IO minutes more at 37°C in a shaker bath. Matched samples containing superoxide dismutase (SOD) (200 U/ sample) were also prepared. The samples were iced and centrifuged (2,OOOg X IO min). The optical density of the supernatants was read at 550 nm, and the nanomoles of SOD-inhibitable superoxide released in I O minutes were calculated with the extinction coefficient of 2.11
Leukocyte Myeloperoxidase Release PMNs (5 X IO6/mL), MNLs (3 X 106/mL), or PMNs (5 X IO6/ mL) plus MNLs (3 X 106/mL) were primed * rhGM-CSFe (8 ng/ mL) for 120 minutes. The cells were then stimulated with fMLP ( I pmol/L X 10 min). The samples were iced and the cells removed by centrifugation (2000g X 10 min). The cell-free supernatants were frozen at -70°C for later myeloperoxidase (MPO) analysis. The cellfree supernatants were assayed spectrophotometrically for MPO release by measuring oxidation of 0-dianisidine." The amount of MPO released was determined by comparing dilutions of the cell-free supernatant activity to a standard curve made by reacting known concentrations of human leukocyte MPO (0 to 3 &mL) with O-diansidine (2 mg/mL) in the presence of hydrogen peroxide (2.5 mmol/ L) for 20 minutes at 23"C, icing the samples, and then reading the optical density at 460 nm. The results are expressed as MPO released (Ilg).
Statistical Analyses
The data were analyzed by Student's two-tailed t-test.
RESULTS
Leukocyte Oxidative Activity
Chemiluminescence
GM-CSF and G-CSF (but not IL-3) prime PMNs and PMN-MNL for increased MLP-stimulated chemiluminescence.
Leukocytes were primed for 120 minutes with or without rhIL-3, rhG-CSF, or rhGM-CSFe (8 ng/mL), then stimulated with fMLP, and peak chemiluminescence recorded. Chemiluminescence in the absence of CSFs was very low for MNLs, PMNs, and PMN-MNL. Priming with rhIL-3 had little effect on leukocyte chemiluminescence. Priming with rhG-CSF caused a small but significant increase in fMLPstimulated PMN chemiluminescence (P = .032) and PMN-MNL chemiluminescence (P = ,045). Recombinant human GM-CSFe primed PMN (P = .002) and PMN-MNL (P = .006) for an increased oxidative response to fMLP and was the most active of the three CSFs. Only with rhGM-CSFe priming was there an indication of interaction between the MNLs and PMNs. The oxidative burst in the PMN-MNL preparation was greater than the sum of the contributions of PMNs and MNLs alone (Fig 1) .
When PMN-MNL were primed with growth factors for 45 minutes and then stimulated with fMLP, priming with rhIL-3 (1 to 8 ng/mL) did not affect chemiluminescence, rhG-CSF (4 to 8 ng/mL) slightly increased chemiluminescence (P < .050), and rhGM-CSFe and rhGM-CSFy (0.2 to 4 ng/mL) markedly increased the fMLP-stimulated oxidative burst (P < .010). There was no significant difference in the chemiluminescence response primed by rhGM-CSFe and rhGMCSFy at any of the assayed concentrations (Fig 2) .
GM-CSF primes PMNs by 45 minutes for increased chemiluminescence in response to fMLP. In the absence of rhGM-CSFe, PMN-MNL displayed very little chemiluminescence in response to fh4LP. Recombinant human GMCSFe (1 ng/mL) primed PMNs for a threefold increase in chemiluminescence in response to fMLP after 45 minutes of incubation (P = .015), and rhGM-CSFe increased PMN-MNL fMLP-stimulated chemiluminescence fivefold by 120 minutes of incubation (P = .003). Priming with rhGM-CSFe did not affect fMLP-stimulated chemiluminescence of MNLs in the absence of PMNs (Fig 3) . There was a dose-response relationship between the number of MNLs (0 to 1 X lo6 MNLs/mL) and the amount of chemiluminescence, especially in the GM-CSF-primed cell preparations (Fig 4) .
The chemiluminescence-enhancing factor(s) appeared to be inherent in MNLs rather than induced by GM-CSF. If the MNLs were primed with rhGM-CSFe ( Purified lymphocytes (-94%) had comparable activity to mixed MNL preparations in enhancing rhGM-CSFe-primed NLP-stimulated PMN chemiluminescence. Chemiluminescence in response to fMLP was 6.96 +-0.71 AU when PMN-MNL were primed for 120 minutes with rhGM-CSFe (1 ng/mL) and then stimulated with N L P (1 pmol/L) compared with 6.86 f 1.12 AU when an equal concentration of purified lymphocytes were substituted for the mixed MNLs ( P = .956). Thus, it appears that purified lymphocytes can enhance GM-CSF-primed fMLP-stimulated PMN chemiluminescence. Growth factor (ng/ml) Because no soluble factor was detected, we examined the possibility that a cell-bound factor was involved. To see if we could maximize priming by increasing cell-to-cell contact, we primed PMNs and PMN-MNL in dispersed suspension (ie, the method employed in the experiments described above) or pelleted by centrifugation into buttons. Following the priming period (60 minutes), all cultures were dispersed by vortex agitation and then chemiluminescence in response to fMLP was measured. We observed that pelleting did not enhance the chemiluminescence response of PMNs with or without GM-CSF, but pelleted PMN-MNL in the presence of rhGM-CSFe (1 ng/mL) had a greater chemiluminescence response than cells that had been primed while dispersed (P = .035) (Fig 6) . Thus, promotion of cell-to-cell contact further enhances priming by GM-CSF in mixed PMN-MNL cultures. Because GM-CSF stimulates tumor necrosis factor alpha (TNF-a) production" and cell-bound TNF can be biologically active.''-*' we examined the role of TNF in GM-CSF-enhanced chemiluminescence. PMNs or PMN-MNL were primed (60 min) with rhGM-CSFe (1 ng/mL) in the presence or absence of 20 WL preimmune rabbit serum or rabbit polyclonal anti-human TNF (200 NU/mL) and then chemiluminescence in response to fMLP was measured. Anti-human TNF (but not preimmune serum) markedly decreased (by -70%) both GM-CSF-primed pure PMNs (P = .014) and mixed PMN-MNL (P = .030) chemiluminescence in response to fMLP (Table 1) .
GM-CSF can stimulate leukocyte production of IL-1 .' ' Anti-IG 1 / 3 (200 NU/mL) decreased rhGM-CSFe (8 ng/mL)-primed mixed PMN-MNL chemiluminescence 18% from 5.06 k 1.45 AU to 4.13 k 1.3 AU ( P = .018). Therefore, IL-1 could be a contributing factor to GM-CSF-primed PMN-MNL oxidative activity.
Superoxide Release
Superoxide release was assayed from pelleted PMN, MNL: and PMN-MNL cell preparations that had been incubated with or without growth factors (1 ng/mL X 60 min). Priming pelleted pure PMNs with rhGM-CSFe resulted in a sevenfold increase in fMLP-stimulated superoxide release ( P = .004), but the addition of MNLs to the PMNs did not further en-GM-CSF, G-CSF, 11-3, AND PMN OXIDATIVE ACTIVITY PMNs or PMN plus MNL were incubated 60 minutes with or without rhGM-CSFe and preimmune rabbit serum or rabbit polyclonal anti-human TNF and then chemiluminescence in response to fMLP was measured. The results are reported as mean relative peak chemiluminescence f SEM (n = three to six separate experiments).
1867
' P < .05 Anti-TNF decreased chemiluminescence compared with no antibody.
hance superoxide release (P = .004 compared with PMN-MNL in the absence of GM-CSF, and P = .132 compared with pure PMN primed with GM-CSF) ( Table 2) .
Recombinant human IL-3 and rhG-CSF did not significantly prime pure PMNs for increased superoxide release in response to fMLP (P = .3 16 and P = .32 1, respectively) nor mixed PMN-MNL (P = .480 and P = .185, respectively) ( Table 2) .
Leukocyte MPO Release
Because luminol-enhanced chemiluminescence is dependent upon myeloperoxidase m~bilization,'~~'~ we assayed the effect of MNLs and rhGM-CSF on PMN degranulation by measuring the release of MPO from the leukocytes into the surrounding medium after stimulation with fMLP. MNL preparations did not release MPO either in the presence or the absence of rhGM-CSF (10 ng/mL). fMLP-stimulated PMN alone released 2.6 pg MPO, MNLs increased this by 
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46% ( P = .002). Recombinant human GM-CSFe (8 ng/mL) increased the release of MPO from PMN 169% ( P = .013), and rhGM-CSFe increased MPO release from PMN-MNL 103% (P = .007) compared with PMN-MNL (Table 3) .
DISCUSSION
Although GM-CSF does not stimulate superoxide release directly from nonadherent PMNs, it primed PMNs for enhanced oxidative activity in response to a second stimulus, including fMLP, the complement component C5a, leukotriene B4, phorbol myristate acetate, and opsonized zymoan.'^-'^ GM-CSF directly stimulates the oxidative activity of PMNs adhered to surfaces coated with extracellular matrix protein^.^' Similar to GM-CSF, G-CSF primes PMNs for increased oxidative activity in response to a second stimulus or adheren~e.~O-~~ Cloned gibbon IL-3 has been reported to stimulate eosinophil superoxide release.37
As has been previously r e p~r t e d ,~~-'~ we observed that pharmacologic concentrations of rhGM-CSF-primed mature human PMNs for increased oxidative activity in response to fMLP, with peak activity occurring after 45 minutes of priming. The greatest oxidative activity was observed in PMN-MNL preparations in which cell-to-cell interaction was maximized. The chemiluminescence was almost threefold higher in pelleted PMN-MNL compared with suspended pure PMNs primed with GM-CSF and then stimulated with fMLP. The role of cell-to-cell contact in cell-to-cell communication (in addition to soluble factors) is becoming evident. For example, it has been observed that live and fixed activated lymphocytes can stimulate PMN superoxide release when cell-to-cell contact is pr~moted.~'
Recently, it has been reported that in vitro incubation with GM-CSF stimulates the expression of IL-I receptors on PMNs. Thus, GM-CSF not only stimulates the production of the inflammatory cytokines TNF and IL-1 ,'',*' but also can increase PMN sensitivity to IL-1 .39 Therefore, the inflammatory action of GM-CSF may be magnified by both increased production and enhanced sensitivity to other inflammatory cytokines.
GM-CSF increases the expression of the adherence factor Mac-1 on PMNs,'~ and stimulates leukocyte aggregati~n.~' Increased cell-to-cell contact through cell aggregation may make the PMNs more sensitive to the enhancing factor(s) on MNLs.
In our experiments, neutralizing polyclonal antibody to TNF decreased the amount of chemiluminescence in both PMN and PMN-MNL cultures primed with rhGM-CSF, indicating that TNF may play a role in the enhancing effect of GM-CSF. Similar to GM-CSF, TNF primes PMNs for increased oxidative activity in response to a second stimulus4I4' and stimulates the oxidative burst of PMNs adherent to biological surfaces.46 Biologically active cell-associated TNF has been found on activated leukocyte^.'^-^' Our data suggest that there is PMN-associated TNF and this TNF is induced by GM-CSF because anti-TNF equally inhibited PMN chemiluminescence in both pure PMN and mixed PMN-MNL preparations and the antibody had little effect in the absence of GM-CSF. It has been reported that production of TNF by PMN is induced by GM-CSF.47 Because the anti-TNF preparation used in these expenments was polyclonal whole rabbit serum, there is the possibility that steric hindrance from the relatively large immunoglobulin molecules binding to the PMNs may contribute to the observed decrease in the oxidative burst by blocking GM-CSF and/or fMLP binding to PMNs.
We observed no difference in priming for the oxidative burst by two recombinant forms of GM-CSF. One was expressed in yeast and the other in Escherichia coli. Native CM-CSF is fully glycosylated; yeast-expressed recombinant GM-CSF is partially glycosylated; and E coli-expressed GM-CSF is nonglycosylated. E coli-expressed recombinant GM-CSF has the same potency as native GM-CSF in stimulating blood progenitor ~e l l s .~~,~~ rhGM-CSFe primed pure PMNs for increased superoxide release in response to fMLP and did not affect MNL superoxide release in response to fMLP. This was similar to results with chemiluminescence. In contrast to what was found with chemiluminescence, the presence of MNLs did not further increase superoxide release from GM-CSF-primed PMNs. Luminol-enhanced chemiluminescence is not directly related to superoxide Chemiluminescence differs from superoxide release in that the chemiluminescence response is dependent, in part, upon MPO mobilization that occurs subsequent to superoxide r e 1 e a~e . l~~'~ As we (Table 3) and others53 have observed, GM-CSF increases PMN mobilization of MPO. The greater effect of MNLs on GM-CSF-primed PMN oxidative activity when assayed by chemiluminescence (compared with superoxide release) thus appears to be related to stimulation of MPO mobilization from the PMNs.
Like rhGM-CSF, rhG-CSF at achievable concentrations primed PMNs for increased chemiluminescence in response to fMLP, but the effect of rhG-CSF was less than with rhGM-CSF. There was no significant effect of rhIL-3 on PMN, MNL, or PMN-MNL chemiluminescence or superoxide release. This is in agreement with Lopez et al,37 who reported that although recombinant gibbon IL-3 stimulates mature human eosinophil function, it has little effect on mature human PMN activity. In addition, our data indicate that unlike GM-CSF, the presence of MNLs does not increase G-CSF-or IL-3-primed PMN oxidative activity.
Recombinant human growth factors have been reported to be effective in promoting leukocyte proliferation in patients For personal use only. on August 29, 2017. by guest www.bloodjournal.org From with a wide range of diseases, including acquire i m m u n e deficiency syndrome (AIDS) and aplastic anemia, and i n patients receiving chemotherapy followed by bone marrow transplantation. Not only the presence, but also the functional state, of the P M N will decide the degree of benefit to the patient. Because the list of growth factors is growing, it is necessary to keep aware of the effects of these factors on mature leukocytes and realize that no single cytokine acts alone b u t rather works within a complex network of inherent and induced factors that may be expressed on the cell surface or released to the surrounding environment. From our experiments, it appears that PMNs are the principal targets of G M -CSF direct action. In addition, GM-CSF, by making the PMNs more responsive to factor(s) in the environment, indirectly increases P M N oxidative activity. 
